These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 23548335)
21. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. Byrne RA; Kastrati A; Massberg S; Wieczorek A; Laugwitz KL; Hadamitzky M; Schulz S; Pache J; Fusaro M; Hausleiter J; Schömig A; Mehilli J; J Am Coll Cardiol; 2011 Sep; 58(13):1325-31. PubMed ID: 21920260 [TBL] [Abstract][Full Text] [Related]
22. New DES: a new step forward? Ko BS; Meredith IT Minerva Cardioangiol; 2012 Feb; 60(1):41-56. PubMed ID: 22322573 [TBL] [Abstract][Full Text] [Related]
23. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. Meredith IT; Verheye S; Dubois CL; Dens J; Fajadet J; Carrié D; Walsh S; Oldroyd KG; Varenne O; El-Jack S; Moreno R; Joshi AA; Allocco DJ; Dawkins KD J Am Coll Cardiol; 2012 Apr; 59(15):1362-70. PubMed ID: 22341736 [TBL] [Abstract][Full Text] [Related]
24. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study. Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312 [TBL] [Abstract][Full Text] [Related]
26. Current and future drug-eluting coronary stent technology. Ielasi A; Latib A; Colombo A Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):485-503. PubMed ID: 21517732 [TBL] [Abstract][Full Text] [Related]
27. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495 [TBL] [Abstract][Full Text] [Related]
28. Update on bioabsorbable stents: from bench to clinical. Waksman R J Interv Cardiol; 2006 Oct; 19(5):414-21. PubMed ID: 17020566 [TBL] [Abstract][Full Text] [Related]
30. One-year clinical outcome of a randomized trial of polymer-free paclitaxel-eluting stents versus biodegradable polymer-based rapamycin-eluting stents in patients with coronary heart disease. Zhang L; Yuan J; Liu G; Zhong JP; Yin YH; She Q; Su L; Ling ZY; Chen YQ J Interv Cardiol; 2012 Dec; 25(6):604-10. PubMed ID: 22384973 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries. Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205 [TBL] [Abstract][Full Text] [Related]
32. A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study. Han YL; Zhang L; Yang LX; Liu HL; Qu P; Li WM; Jiang TM; Li SM; Jing QM; Zhang QY; Xu B; Li Y; Gao RL EuroIntervention; 2012 Nov; 8(7):815-22. PubMed ID: 23171802 [TBL] [Abstract][Full Text] [Related]
33. Drug-eluting bioresorbable stents for various applications. Zilberman M; Eberhart RC Annu Rev Biomed Eng; 2006; 8():153-80. PubMed ID: 16834554 [TBL] [Abstract][Full Text] [Related]
34. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process. Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978 [TBL] [Abstract][Full Text] [Related]
35. [Biodegradable polymer-coated - new step in coronary arteriosclerosis intervention]. Siminiak T Kardiol Pol; 2010 May; 68(5):510-1. PubMed ID: 20491009 [No Abstract] [Full Text] [Related]
36. Promise and challenges of bioabsorbable stents. Waksman R Catheter Cardiovasc Interv; 2007 Sep; 70(3):407-14. PubMed ID: 17722019 [TBL] [Abstract][Full Text] [Related]
37. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts. Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438 [TBL] [Abstract][Full Text] [Related]
38. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry. Buszman P; Trznadel S; Milewski K; Rzeźniczak J; Przewłocki T; Kośmider M; Wójcik J; Janczak J; Zurakowski A; Kondys M; Król M; Kinasz L; Jaklik A; Rzeszutko Ł; Kałuza GL; Kiesz S; Gil R Catheter Cardiovasc Interv; 2008 Jan; 71(1):51-7. PubMed ID: 18098182 [TBL] [Abstract][Full Text] [Related]
39. A review of current devices and a look at new technology: drug-eluting stents. Nakazawa G; Finn AV; Kolodgie FD; Virmani R Expert Rev Med Devices; 2009 Jan; 6(1):33-42. PubMed ID: 19105778 [TBL] [Abstract][Full Text] [Related]
40. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications. Bourantas CV; Onuma Y; Farooq V; Zhang Y; Garcia-Garcia HM; Serruys PW Int J Cardiol; 2013 Jul; 167(1):11-21. PubMed ID: 22748288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]